4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0000950170-25-002813
Interim CFO sold 261 shares at $5.63 ($1,469)
- Interim CFO acquired 726 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Firmani Lori Interim CFO | 2025-01-03 | Option exercise | +726 | 726 | D | ||
| Firmani Lori Interim CFO | 2025-01-03 | Sale | −261 | $5.63 | $1,469 | 465 | D |
| Derivatives | |||||||
| Firmani Lori Interim CFO | 2025-01-03 | Option exercise · Restricted Stock Units | −726 | 1,474 | D | ||
| Firmani Lori Interim CFO | 2025-01-03 | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | D | ||
| Open-market sales · 261 sh · avg $5.63 · $1,469 | |||||||
Loading xslF345X05/ownership.xml…